Ganesha
Ganesha.svg
Ganesha3d.png
Names
Preferred IUPAC name
1-(2,5-Dimethoxy-3,4-dimethylphenyl)propan-2-amine
Other names
3,4-Dimethyl-2,5-dimethoxyamphetamine;
2-(3,4-Dimethyl-2,5-dimethoxyphenyl)-1-methyl-1-aminoethane
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C13H21NO2/c1-8(14)6-11-7-12(15-4)9(2)10(3)13(11)16-5/h7-8H,6,14H2,1-5H3 checkY
    Key: RBZXVDSILZXPDM-UHFFFAOYSA-N checkY
  • InChI=1/C13H21NO2/c1-8(14)6-11-7-12(15-4)9(2)10(3)13(11)16-5/h7-8H,6,14H2,1-5H3
    Key: RBZXVDSILZXPDM-UHFFFAOYAA
  • COc1c(C)c(C)c(cc1CC(C)N)OC
Properties
C13H21NO2
Molar mass 223.316 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

Ganesha (2,5-dimethoxy-3,4-dimethylamphetamine) is a lesser-known psychedelic drug. It is also a substituted amphetamine. It was first synthesized by Alexander Shulgin.[citation needed] In his book PiHKAL, the dosage range is listed as 24–32 mg.[1] The drug is usually taken orally, although other routes such as rectally may also be used.[citation needed] Ganesha is synthesized from 2,5-dimethoxy-3,4-dimethylbenzaldehyde. Ganesha is the amphetamine analog of 2C-G. It is a particularly long lasting drug, with the duration listed in PiHKAL as being 18–24 hours, which might make it undesirable to some users. It is named after the Hindu deity, Ganesha. Very little is known about the dangers or toxicity of ganesha. Effects of ganesha include:[1]

Homologues

G-3

G-3
G-3

2,5-Dimethoxy-3,4-(trimethylene)amphetamine:[2]

G-4

G-4
G-4

2,5-Dimethoxy-3,4-(tetramethylene)amphetamine:[3]

G-5

3,6-Dimethoxy-4-(2-aminopropyl)benzonorbornane:[4]

G-N

G-N
G-N

1,4-Dimethoxynaphthyl-2-isopropylamine:[5]

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[6]

See also

References

  1. ^ a b Ganesha Entry in PiHKAL
  2. ^ G-3 entry in PiHKAL
  3. ^ G-4 entry in PiHKAL
  4. ^ G-5 entry in PiHKAL
  5. ^ G-N entry in PiHKAL
  6. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.